4//SEC Filing
Disbrow Joshua R. 4
Accession 0000912282-23-000133
CIK 0001385818other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 1:52 PM ET
Size
5.3 KB
Accession
0000912282-23-000133
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Purchase
Common Shares
2023-06-14$1.86/sh+14,000$26,079→ 71,591 total
Footnotes (2)
- [F1]The purchase price reported in Column 4 above is an average weighted price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023.
Documents
Issuer
AYTU BIOPHARMA, INC
CIK 0001385818
Entity typeother
Related Parties
1- filerCIK 0001566240
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 1:52 PM ET
- Size
- 5.3 KB